These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19200600

  • 21. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T, Morgan BP, Meri S.
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [Abstract] [Full Text] [Related]

  • 22. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.
    Hu W, Yu Q, Hu N, Byrd D, Amet T, Shikuma C, Shiramizu B, Halperin JA, Qin X.
    J Immunol; 2010 Jan 01; 184(1):359-68. PubMed ID: 19955519
    [Abstract] [Full Text] [Related]

  • 23. Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration.
    Feng D, Dai S, Liu F, Ohtake Y, Zhou Z, Wang H, Zhang Y, Kearns A, Peng X, Zhu F, Hayat U, Li M, He Y, Xu M, Zhao C, Cheng M, Zhang L, Wang H, Yang X, Ju C, Bryda EC, Gordon J, Khalili K, Hu W, Li S, Qin X, Gao B.
    J Clin Invest; 2016 Jun 01; 126(6):2321-33. PubMed ID: 27159394
    [Abstract] [Full Text] [Related]

  • 24. Production and functional characterization of a soluble recombinant form of mouse CD59.
    Rushmere NK, Van Den Berg CW, Morgan BP.
    Immunology; 2000 Feb 01; 99(2):326-32. PubMed ID: 10692054
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis.
    Tomlinson S, Wang Y, Ueda E, Esser AF.
    J Immunol; 1995 Jul 01; 155(1):436-44. PubMed ID: 7541424
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.
    Li B, Gao MH, Chu XM, Xu YJ, Yang F.
    Cell Oncol (Dordr); 2012 Oct 01; 35(5):355-65. PubMed ID: 22945508
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rapid degradation of the complement regulator, CD59, by a novel inhibitor.
    Cai B, Xie S, Liu F, Simone LC, Caplan S, Qin X, Naslavsky N.
    J Biol Chem; 2014 Apr 25; 289(17):12109-12125. PubMed ID: 24616098
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High-resolution structures of bacterially expressed soluble human CD59.
    Leath KJ, Johnson S, Roversi P, Hughes TR, Smith RA, Mackenzie L, Morgan BP, Lea SM.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug 01; 63(Pt 8):648-52. PubMed ID: 17671359
    [Abstract] [Full Text] [Related]

  • 38. Insights into the human CD59 complement binding interface toward engineering new therapeutics.
    Huang Y, Smith CA, Song H, Morgan BP, Abagyan R, Tomlinson S.
    J Biol Chem; 2005 Oct 07; 280(40):34073-9. PubMed ID: 16079145
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.